Skip to main content
LS

LSL Pharma Group

Boucherville, Canada
Last funding
$8.7M
Post-IPO DebtDec 2025

LSL Pharma Group is a manufacturing company that innovates and manufactures life sciences products.

About LSL Pharma Group

How much funding has LSL Pharma Group raised?

LSL Pharma Group has raised $8.7M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in December 2025.

Who are LSL Pharma Group's investors?

LSL Pharma Group's investors include Business Development Bank of Canada, Desjardins.

Where is LSL Pharma Group headquartered?

LSL Pharma Group is headquartered in Boucherville, Canada.

What does LSL Pharma Group do?

LSL Pharma Group is a manufacturing company that innovates and manufactures life sciences products.

What stage is LSL Pharma Group at?

LSL Pharma Group is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"LSL Pharma Group — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/lsl-pharma-group. Accessed August 16, 2026.
APA
VCBacked. (2025). LSL Pharma Group — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/lsl-pharma-group
Wikipedia (cite web)
{{cite web |title=LSL Pharma Group — Funding & Investors |url=https://www.vcbacked.co/company/lsl-pharma-group |website=VCBacked |access-date=August 16, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Founder contacts
m***@groupelslpharma.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →